PBE
$77.97
Invesco Biotechnology & Genome ETF
Fund Family: Unknown
Explore sections
1 Month
+10.33%
YTD
+10.11%
1 Year
+10.11%
3 Year
+20.19%
Top 10 Holdings (47.9% of portfolio)
- Alnylam Pharmaceuticals IncUnknown6.70%
- Illumina IncUnknown6.17%
- Amgen IncUnknown5.23%
- Gilead Sciences IncUnknown5.10%
- Vertex Pharmaceuticals IncUnknown5.07%
- BioMarin Pharmaceutical IncUnknown4.93%
- United Therapeutics CorpUnknown4.32%
- Anavex Life Sciences CorpUnknown4.14%
- Protagonist Therapeutics IncUnknown3.13%
- Incyte CorpUnknown3.10%
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals Inc | ALNY | Unknown | 6.70% |
| 2 | Illumina Inc | ILMN | Unknown | 6.17% |
| 3 | Amgen Inc | AMGN | Unknown | 5.23% |
| 4 | Gilead Sciences Inc | GILD | Unknown | 5.10% |
| 5 | Vertex Pharmaceuticals Inc | VRTX | Unknown | 5.07% |
| 6 | BioMarin Pharmaceutical Inc | BMRN | Unknown | 4.93% |
| 7 | United Therapeutics Corp | UTH | Unknown | 4.32% |
| 8 | Anavex Life Sciences Corp | AVXL | Unknown | 4.14% |
| 9 | Protagonist Therapeutics Inc | PTGX | Unknown | 3.13% |
| 10 | Incyte Corp | INCY | Unknown | 3.10% |
Fund Information
Net AssetsN/A
Total Holdings28
Fund FamilyUnknown